India to Germany: Budesonide Export Trade Route

The India to Germany Budesonide corridor is one of India's established pharmaceutical export routes, with 30 shipments documented worth a combined $1.9M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's budesonide manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $63.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with budesonide's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 31.8%, placing it at rank #14 among India's top budesonide export destinations globally.

On the import side, key buyers of Indian budesonide in Germany include ESPARMA Pharma Services GmbH, ESPARMA PHARMA SERVICES GMBH, SALUTAS PHARMA GMBH. and 3 others. ESPARMA Pharma Services GmbH is the single largest importer with 17 shipments valued at $1.3M USD.

India's budesonide exports to Germany are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 29 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Germany benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, SENTISS PHARMA PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $63.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as budes n inhaler 0.2mg budesonide 200mcgpack size:1x200md and budes n inhaler 0.2mg triple packbudesonide 200mcgpack size:3 x 200md x 7896 pack=23688 nos, suggesting that buyers in Germany tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ESPARMA Pharma Services GmbH is the largest importer with 17 shipments worth $1.3M USD — representing 66% of all budesonide imports from India on this route. A total of 6 buyers are active on this corridor.